Logo
DCA

Johnson & Johnson

sp500
JNJHealthcareDrug Manufacturers - General
$253.04
+1.23%
Last Price
$253.04
2026-07-17
24h Change
+1.23%
3.07 USD
Volume
7.5M
Shares Traded
Data Reliability
High
16243 points (65 years)

Price History

Start a simulation with this asset

JNJ

Global parameters

Available data from 1/2/1962 to 7/17/2026

Fundamental Analysis

New
CAGR (5y)
5.60%
Revenue Growth
Net Margin
28.46%
Profitability
ROE
32.87%
Return on Equity
Debt / EBITDA
1.17
Solvency
PEG Ratio
5.05
Valuation vs Growth
Rev. Growth (TTM)
9.90%
Current Trend

PE Ratio History (5 Years)

Historical PE
Average (21.5x)
Current: 30.5x
Technical focus
JNJ
30d volatility
22.78%
Distance to MA50
6.03%
Distance to MA200
13.51%
Distance to ATH
-5.31%
Momentum 3M
8.05%
Risk score
N/A

Volatility moderate. Momentum neutral.

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Invest in this asset
Buy on Saxo Bank
🏦Regulated Broker
🌍Global Markets Access
📈Pro Tools

Ad link. Capital at risk.

Technical Analysis & Risk

Key Metrics

CAGR11.53%
Volatility22.78%
Max Drawdown-18.58%

Momentum : JNJ

Indicateur synthétique
PEURNEUTREAVIDITÉ
68
Greed

Risk Analysis

VaR (95%)-2.13%
DCA Health
95/100

Recent History (60 days)

DateCloseVolume
2026-07-17$253.047,516,376
2026-07-16$249.978,712,227
2026-07-15$247.0210,005,307
2026-07-14$253.856,374,562
2026-07-13$257.773,873,681
2026-07-10$256.985,217,403
2026-07-09$259.106,294,135
2026-07-08$263.406,769,400
2026-07-07$267.249,081,600
2026-07-06$259.335,081,102
2026-07-02$263.047,901,835
2026-07-01$253.986,511,339
2026-06-30$253.974,525,237
2026-06-29$258.518,437,817
2026-06-26$254.6616,242,949
2026-06-25$244.8810,031,648
2026-06-24$241.005,041,625
2026-06-23$239.087,590,889
2026-06-22$231.298,393,040
2026-06-18$228.3918,736,849
2026-06-17$234.208,442,711
2026-06-16$235.187,021,889
2026-06-15$235.667,485,697
2026-06-12$240.876,455,583
2026-06-11$238.334,861,556
2026-06-10$238.496,956,293
2026-06-09$237.008,191,819
2026-06-08$232.167,529,093
2026-06-05$232.775,636,649
2026-06-04$228.177,214,694
2026-06-03$223.244,565,701
2026-06-02$222.893,676,189
2026-06-01$223.515,962,384
2026-05-29$225.336,188,580
2026-05-28$230.806,733,852
2026-05-27$231.295,835,500
2026-05-26$230.186,427,813
2026-05-22$234.345,460,721
2026-05-21$231.735,196,882
2026-05-20$229.323,376,613
2026-05-19$230.006,002,888
2026-05-18$228.929,222,828
2026-05-15$226.7111,232,375
2026-05-14$230.803,037,929
2026-05-13$230.425,327,127
2026-05-12$224.268,349,434
2026-05-11$221.433,625,123
2026-05-08$221.323,850,388
2026-05-07$222.516,771,465
2026-05-06$224.627,823,079
2026-05-05$225.555,271,298
2026-05-04$224.208,151,408
2026-05-01$227.196,022,437
2026-04-30$229.858,143,777
2026-04-29$227.356,884,458
2026-04-28$227.795,428,778
2026-04-27$225.345,498,001
2026-04-24$227.505,778,847
2026-04-23$230.656,947,896
2026-04-22$226.106,637,218

Recent Dividends

DateAmount
2026-02-24+$1.30
2025-11-25+$1.30
2025-08-26+$1.30
2025-05-27+$1.30
2025-02-18+$1.24
2024-11-26+$1.24
2024-08-27+$1.24
2024-05-20+$1.24
2024-02-16+$1.19
2023-11-20+$1.19
2023-08-25+$1.19
2023-05-22+$1.19
2023-02-17+$1.13
2022-11-21+$1.13
2022-08-22+$1.13
2022-05-23+$1.13
2022-02-18+$1.06
2021-11-22+$1.06
2021-08-23+$1.06
2021-05-24+$1.06

Related Assets